🔎 Trials Near Me

Home › Obstructive Sleep Apnea › NCT06189755

MicroRNAs as Biomarkers for Obstructive Sleep Apnea

RecruitingObservational study

Who can join

Ages 18 to 75 · All sexes

Full eligibility criteria
Inclusion Criteria for Cases:

* age 18-75 years
* moderate-severe OSA (defined as AHI ≥15 events/hour)
* willing to accept PAP therapy

Inclusion Criteria for Controls:

* age 18-75 years
* no OSA (defined as AHI \<5 events/hour)

Exclusion Criteria for Cases:

* current use of PAP or other OSA treatments
* home oxygen therapy
* recent changes (within 3 months) to BP medications among those who are on these medications
* presence of Cheyne-Stokes Respiration (CSR) in sleep study
* predominantly central sleep apnea (AHI≥15 events/hour, with \>50% central events)
* pregnancy
* clinical history of chronic kidney disease (Stage 5) requiring dialysis, or renal transplant
* organ transplantation
* self-reported sleep duration less than 5 hours per night on weeknights (work nights)
* current night shift work

Exclusion Criteria for Controls:

* home oxygen therapy
* pregnancy
* clinical history of chronic kidney disease (Stage 5) requiring dialysis, or renal transplant
* organ transplantation
* self-reported sleep duration less than 5 hours per night on weeknights (work nights)
* current night shift work

About the study

Although obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop and validate blood biomarkers that are specific to OSA, useful for identification of cases with OSA, reflective of efficacy of therapy, and able to predict blood pressure response to treatment of OSA.

What is being tested

Sponsor: University of Pennsylvania · Participants: 500 · Started: Apr 1, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06189755

Locations in the U.S.

OhioThe Ohio State University - Martha Morehouse Medical Pavilion, Suite 2600, Columbus
PennsylvaniaUniversity of Pennsylvania, Philadelphia

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.